Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 September 2018 Photo Hanno Otto
Consecutive international win for OSM Camerata
The OSM Camerata is once again a winner, sharing the first prize in the Ictus International Music Competition with the Oklahoma State University.

If Einstein’s string theory had a musical undertone, one would think it is because of the sweet melodies of the Odeion School of Music Cameratas’ (OSMC) violins and cellos. It should therefore come as no surprise that OSMC won the 2018 International Ictus Music Competition, again. The ensemble has been paving the way to numerous successes since its inception in 2012.

This year, however, the OSMC is sharing the first prize with the Oklahoma State University Symphony Orchestra, under the direction of Dr Thomas Dickey. The OSMC’s competition recital for 2018 was conducted by principle conductor, Xavier Cloete. Acclaimed violist Elsabé Raath, joined the OSMC artistic team in 2017 as string clinician.

OSMC the jewel in crown

The OSMC is based at the Odeion School of Music (OSM) at the University of the Free State UFS) and was strategically founded as the OSM’s flagship ensemble with the main objective, creating a catalyst for excellence. “From a pedagogical perspective, it serves as a feasible incubator to nurture fully-rounded musicians who are thoroughly prepared for the demands of their trade as orchestral musicians, soloists and conductors,” said Marius Coetzee founder of the OSMC.

“Ms Raath also made her debut as conductor during the 2018 Ictus Music Competition where she conducted O Sacrum Convivium by Olivier Messiaen,” said Coetzee, founder of the OSMC. Elsabé was also conductor during the 2018 Ictus Music competition.

The OSMC’s concert programme for Ictus 2018 also consisted of works by Jacobus Gallus/Lance Phillip, Béla Bartók, Peteris Vasks/Keith Moss, as well as Johann Sebastian Bach.

Ictus an ideal platform


The Ictus International Music Competition is an online music competition for wind bands, orchestras and solo trumpet. It has been described by David Bilger of the Philadelphia Orchestra as “democratising music competitions”. Ictus was founded to make international music competitions more accessible though eliminating prohibitive travel costs, conference fees and visa issues. This was made possible through having the application and adjudication take place online only. 

You can listen to OMSC Ictus submissions here:

Duo Seraphim Jabobus Gallus/Lance Phillip
Romanian Folk Dances/ Román népi táncok Béla Bartók
Kekatu Dziesma (Carnival Song) Peteris Vasks/Keith Moss

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept